
|Articles|March 3, 2008
Post-marketing liver injury reports lead to Tysabri PI update
Liver injury warnings added to natalizumab prescribing information.
Advertisement
Reports of markedly elevated serum hepatic enzymes and elevated total bilirubin in patients receiving natalizumab (
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Expansion of OTC Contraceptive Could Fill Reproductive Health Disparities
2
Q&A: Fentanyl, Opiophobia Concurrently Contribute to Ongoing Opioid Crisis
3
Finerenone Shows Benefits for Chronic Kidney Disease for Patients With Type 1 Diabetes
4
Pharmacists’ Expanding Roles in Diabetes, Community Health Care
5




















































































































































